Literature DB >> 12684632

Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.

Nanna Junker1, Scilla Latini, Lone N Petersen, Paul E G Kristjansen.   

Abstract

Hyaluronan and hyaluronidases have been proposed to be involved in tumor angiogenesis and invasion. Three hyaluronidases, HYAL1, HYAL2 and HYAL3, are located at the chromosomal region 3p21. In most small cell lung cancer (SCLC) lines the 3p21 region is part of a homozygote or heterozygote deletion. Gliomas are known to exist in a hyaluronan rich environment and express high levels of the hyaluronan receptor CD44. In a panel of SCLC and glioma cell lines the expression of HYAL1, HYAL2 and HYAL3 mRNA was examined. It was observed that the cell lines differed in their ability to splice out a retained intron in the 5' UTR of HYAL1 mRNA. A correlation seems to exist between the ability to splice out the retained 5' end intron of HYAL1 mRNA and the general hyaluronidase activity. In one cell line a substantial part of the hyaluronidase activity was abolished by immunoprecipitation of Hyal1, which strongly indicates that Hyal1 is the principal hyaluornidase in the examined cell lines. During severe hypoxia a significant reduction in both hyaluronidase mRNA and protein activity was found. These results support the theory of involvement of hyaluronidase in the angiogenic and invasive front of tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684632

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

Review 2.  Hyaluronidases: their genomics, structures, and mechanisms of action.

Authors:  Robert Stern; Mark J Jedrzejas
Journal:  Chem Rev       Date:  2006-03       Impact factor: 60.622

3.  Tackling gliomas with nanoformulated antineoplastic drugs: suitability of hyaluronic acid nanoparticles.

Authors:  M Ganau
Journal:  Clin Transl Oncol       Date:  2013-09-27       Impact factor: 3.405

4.  Involvement of hyaluronidases in colorectal cancer.

Authors:  Helen Bouga; Isidoros Tsouros; Dimitrios Bounias; Dora Kyriakopoulou; Michael S Stavropoulos; Nikoletta Papageorgakopoulou; Dimitrios A Theocharis; Demitrios H Vynios
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

Review 5.  Hyaluronan: a simple polysaccharide with diverse biological functions.

Authors:  Kevin T Dicker; Lisa A Gurski; Swati Pradhan-Bhatt; Robert L Witt; Mary C Farach-Carson; Xinqiao Jia
Journal:  Acta Biomater       Date:  2013-12-18       Impact factor: 8.947

Review 6.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 7.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

Review 8.  Mechanisms of angiogenesis in gliomas.

Authors:  O Kargiotis; J S Rao; A P Kyritsis
Journal:  J Neurooncol       Date:  2006-03-23       Impact factor: 4.130

9.  Expression and activity of hyaluronidases HYAL-1, HYAL-2 and HYAL-3 in the human intervertebral disc.

Authors:  Olga Krupkova; Helen Greutert; Norbert Boos; Johannes Lemcke; Thomas Liebscher; Karin Wuertz-Kozak
Journal:  Eur Spine J       Date:  2019-11-22       Impact factor: 3.134

10.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Authors:  Feng Jiang; Zhengnan Yin; Nancy P Caraway; Ruiyun Li; Ruth L Katz
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.